EMILY CLARK: Open Payments
NPI 1568744829 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 27 payments from 10 companies in 2025. Trend: 2023 $269 · 2024 $386 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $105 |
| Biogen, Inc. | 3 | $84 |
| Exeltis, USA Inc. | 5 | $82 |
| Sumitomo Pharma America, Inc. | 4 | $74 |
| Astellas Pharma US Inc | 2 | $64 |
| Hologic Sales and Service, LLC | 2 | $57 |
| Novo Nordisk Inc | 2 | $29 |
| SHIELD THERAPEUTICS INC | 2 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $16 |
Products named: ZURZUVAE, SLYND, Veozah, VRAYLAR, MYFEMBREE, Sonata Sonography-Guided Transcervical Fibroid Ablation System, QULIPTA, ACCRUFER.
Industry payments across KY — which companies pay providers there.
